Insider selling
Traded Mar 12 · filed 11 days laterNot reported under a pre-arranged trading plan
An Elevance Health director sold $7.5K of Elevance Health shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Mar 6, 2026 · Filed Mar 9, 2026
Elevance Health's & President, Commercial sold $911K of Elevance Health shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$910,604
Shares × reported transaction price
37 days after results of Jan 28, 2026, 47 days before results of Apr 22, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $289.64 on Mar 6, 2026, 5% above its 52-week low and 36% below its high, after a 22% drop over the previous 30 trading days
52-week range $274.66 (Aug 1, 2025) to $452.69 (Apr 3, 2025), 8% of the way up, from 251 adjusted closes. 30 trading days earlier: $372.24 on Jan 22, 2026. Describes the past only, not a forecast
RSI 31, 14% under its 200-day average, 16% under its 50-day average, 36% below the 52-week high, 20-day volatility 43% a year, against the S&P 500: −13 points over 1 month, −11 points over 3 months, −10 points over 6 months
From the adjusted closes up to Mar 6, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on May 12, 2025 in the U.S. District Court, S.D. Indiana. A filing is an allegation, not a finding.
MILLER v. ELEVANCE HEALTH, INC., docket 1:25-cv-00923, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.6% | −0.9% | +5.6% |
| 30 days | +12.1% | +0.4% | +11.7% |
| 90 days | +47.9% | +9.2% | +38.8% |
| 180 days | +42.2% | +13.1% | +29.1% |
Past results only. Not a forecast.
Insider selling
Traded Mar 12 · filed 11 days laterNot reported under a pre-arranged trading plan
An Elevance Health director sold $7.5K of Elevance Health shares. The filing does not indicate a pre-arranged trading plan.
Insider buying
Their first buy on recordTraded Mar 5 · filed 1 day later
An Elevance Health director paid $870K out of pocket for Elevance Health shares. Shares held went up 470% with this purchase.
Insider filing
Traded Mar 2 · filed 2 days later
Routine share withholding; mechanical by default.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.